Design, development, and characterisation of clofazimine-loaded mannosylated nanostructured lipid carriers: 3<sup>3</sup>-Box-Behnken design approach
Tulshidas S. Patil, Ashwini Deshpande
Abstract
The Mycobacterium Tuberculosis infection can be treated via clofazimine (CLF)-loaded nanostructured lipid carriers (NLCs). Precipitation-hot microemulsification-probe sonication method was employed for formulation of CLF-NLCs and optimised by using 33 Box–Behnken design. The surface of CLF-NLCs was modified with mannose ligands. The mannose modified and bare CLF-NLC formulations show highest encapsulation efficiencies greater than 70%. The preliminary evaluations were performed by using analytical techniques like Fourier transform infrared spectroscopy, differential scanning colorimetry, and powder X-ray diffraction studies. In-vitro drug release studies showed pH-dependent, sustained drug release profiles and best fitted for first order and Higuchi kinetics. The spherical morphologies of NLCs were confirmed by field-emission scanning electron microscopy. The formulations showed high storage stability at ambient and refrigerated conditions. Thus, present research successfully demonstrated the application of QbD principles in developing CLF-NLCs and improved the performance of CLF.